Want to see COLL full AI Analyst Report?
Collegium Pharmaceutical (COLL) Q3 2023 Earnings Report
COLL Q3 2023 EPS Results
- Actual EPS
- $1.34
- Consensus EPS
- $1.22
- Beat/Miss
- Beat by +$0.12
- One Year Ago EPS
- $1.10
COLL Q3 2023 Revenue Results
- Actual Revenue
- $136.71M
- Expected Revenue
- $137.27M
- Beat/Miss
- Missed by -$560.00K
- YoY Revenue Growth
- +7.63%
Earnings Announcement Details
- Quarter
- Q3 2023
- Date
- 11/07/2023
- Time
- After Close
- Conference Call
- Tuesday, November 7, 2023
COLL Upcoming Earnings
Collegium Pharmaceutical's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q3 2023 Earnings Call Audio
COLL Q3 2023 Earnings Call
0:00 / 0:00
Q3 2023 Earnings Slide Deck
Q3 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
COLL Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | 1.86- | 2.25 | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | 1.721.92 | 1.68 | 14.29% (+0.24) | |
| May 07, 2026 | 2026 (Q1) | 1.521.76 | 1.49 | 18.12% (+0.27) | |
| Feb 26, 2026 | 2025 (Q4) | 2.142.04 | 1.77 | 15.25% (+0.27) | |
| Nov 06, 2025 | 2025 (Q3) | 1.862.25 | 1.61 | 39.75% (+0.64) | |
| Aug 07, 2025 | 2025 (Q2) | 1.621.68 | 1.62 | 3.70% (+0.06) | |
| May 08, 2025 | 2025 (Q1) | 1.431.49 | 1.45 | 2.76% (+0.04) | |
| Feb 27, 2025 | 2024 (Q4) | 1.541.77 | 1.58 | 12.03% (+0.19) | |
| Nov 07, 2024 | 2024 (Q3) | 1.591.61 | 1.34 | 20.15% (+0.27) | |
| Aug 08, 2024 | 2024 (Q2) | 1.491.62 | 1.26 | 28.57% (+0.36) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
